Results 281 to 290 of about 79,918 (320)
Some of the next articles are maybe not open access.
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Neuronal Nicotinic Acetylcholine Receptors
1998Nicotinic acetylcholine receptors (AChR) are prototypical members of the neurotransmitter-gated superfamily of ion channels (ionotropic neurotransmitter receptors; see Figure 7.1; see chapters 2,5, and 6 in this volume).‡ AChR mediate some of the effects of the endogenous neurotransmitter, acetylcholine (ACh), and they are principal biological targets ...
openaire +1 more source
[68] Nicotinic acetylcholine receptors
1977Publisher Summary Nicotinic acetylcholine receptors are integral proteins of the subsynaptic membranes of skeletal muscle and of homologous electrocytes of electric fish. These receptors translate the binding of acetylcholine into an increase in the permeability of the membrane to sodium, potassium, and calcium ions.
openaire +1 more source
Nicotinic acetylcholine receptors: An overview
Biochemical Pharmacology, 1984J O, Dolly, E A, Barnard
openaire +2 more sources
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly